• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 限制放松后哮喘恶化的反弹:一项基于人群的纵向研究(COVIDENCE UK)。

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).

机构信息

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

出版信息

Thorax. 2023 Aug;78(8):752-759. doi: 10.1136/thorax-2022-219591. Epub 2022 Nov 23.

DOI:10.1136/thorax-2022-219591
PMID:36423925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10359556/
Abstract

BACKGROUND

The imposition of restrictions on social mixing early in the COVID-19 pandemic was followed by a reduction in asthma exacerbations in multiple settings internationally. Temporal trends in social mixing, incident acute respiratory infections (ARI) and asthma exacerbations following relaxation of COVID-19 restrictions have not yet been described.

METHODS

We conducted a population-based longitudinal study in 2312 UK adults with asthma between November 2020 and April 2022. Details of face covering use, social mixing, incident ARI and severe asthma exacerbations were collected via monthly online questionnaires. Temporal changes in these parameters were visualised using Poisson generalised additive models. Multilevel logistic regression was used to test for associations between incident ARI and risk of asthma exacerbations, adjusting for potential confounders.

RESULTS

Relaxation of COVID-19 restrictions from April 2021 coincided with reduced face covering use (p<0.001), increased frequency of indoor visits to public places and other households (p<0.001) and rising incidence of COVID-19 (p<0.001), non-COVID-19 ARI (p<0.001) and severe asthma exacerbations (p=0.007). Incident non-COVID-19 ARI associated independently with increased risk of asthma exacerbation (adjusted OR 5.75, 95% CI 4.75 to 6.97) as did incident COVID-19, both prior to emergence of the omicron variant of SARS-CoV-2 (5.89, 3.45 to 10.04) and subsequently (5.69, 3.89 to 8.31).

CONCLUSIONS

Relaxation of COVID-19 restrictions coincided with decreased face covering use, increased social mixing and a rebound in ARI and asthma exacerbations. Associations between incident ARI and risk of severe asthma exacerbation were similar for non-COVID-19 ARI and COVID-19, both before and after emergence of the SARS-CoV-2 omicron variant.

STUDY REGISTRATION NUMBER

NCT04330599.

摘要

背景

在 COVID-19 大流行早期实施社交限制后,国际上多个地区的哮喘恶化情况有所减少。但 COVID-19 限制放松后社交混合、新发急性呼吸道感染(ARI)和哮喘恶化的时间趋势尚未被描述。

方法

我们在 2020 年 11 月至 2022 年 4 月期间,对 2312 名英国哮喘成年人进行了一项基于人群的纵向研究。通过每月在线问卷收集面部覆盖物使用、社交混合、新发 ARI 和严重哮喘恶化的详细信息。使用泊松广义加性模型可视化这些参数的时间变化。使用多水平逻辑回归检验新发 ARI 与哮喘恶化风险之间的关联,并调整潜在混杂因素。

结果

2021 年 4 月 COVID-19 限制放宽,与此同时,面部覆盖物使用减少(p<0.001),室内前往公共场所和其他家庭的频率增加(p<0.001),COVID-19(p<0.001)、非 COVID-19 ARI(p<0.001)和严重哮喘恶化(p=0.007)的发病率上升。新发非 COVID-19 ARI 与哮喘恶化风险独立相关(调整后的比值比 5.75,95%置信区间 4.75 至 6.97),新发 COVID-19 也是如此,包括在 SARS-CoV-2 奥密克戎变异株出现之前(5.89,3.45 至 10.04)和之后(5.69,3.89 至 8.31)。

结论

COVID-19 限制放宽,面部覆盖物使用减少,社交混合增加,ARI 和哮喘恶化反弹。新发 ARI 与严重哮喘恶化风险之间的关联,在非 COVID-19 ARI 和 COVID-19 之间相似,无论 SARS-CoV-2 奥密克戎变异株出现与否。

研究注册号

NCT04330599。

相似文献

1
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).COVID-19 限制放松后哮喘恶化的反弹:一项基于人群的纵向研究(COVIDENCE UK)。
Thorax. 2023 Aug;78(8):752-759. doi: 10.1136/thorax-2022-219591. Epub 2022 Nov 23.
2
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study.自加强疫苗接种以来的时间与新冠病毒相关哮喘加重的新冠病毒疾病严重程度及风险:来自英国COVIDENCE研究数据的纵向分析
BMJ Open Respir Res. 2025 May 15;12(1):e003158. doi: 10.1136/bmjresp-2025-003158.
3
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK).新冠病毒(COVID-19)发病风险因素:基于人群的纵向研究(COVIDENCE UK)。
Thorax. 2022 Sep;77(9):900-912. doi: 10.1136/thoraxjnl-2021-217487. Epub 2021 Nov 30.
4
Odds of COVID-19-associated asthma exacerbations in children higher during Omicron wave.奥密克戎变异株流行期间儿童 COVID-19 相关哮喘恶化的几率更高。
Pediatr Pulmonol. 2023 Nov;58(11):3179-3187. doi: 10.1002/ppul.26642. Epub 2023 Aug 18.
5
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
6
Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 Pandemic.全港性研究:新冠疫情下因哮喘恶化而住院的情况。
Ann Am Thorac Soc. 2021 Oct;18(10):1624-1633. doi: 10.1513/AnnalsATS.202010-1247OC.
7
Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures.在采取严格缓解措施的冠状病毒病大流行期间儿童哮喘恶化的频率。
Pediatr Pulmonol. 2021 Jun;56(6):1455-1463. doi: 10.1002/ppul.25335. Epub 2021 Mar 8.
8
Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus.研究 COVID-19 大流行对社区病毒流行和医疗保健利用的影响表明,随着鼻病毒/肠道病毒的再次出现,哮喘、COPD 和呼吸道感染的高峰期出现。
Thorax. 2023 Dec;78(12):1248-1253. doi: 10.1136/thorax-2022-219957. Epub 2023 Jul 9.
9
Ambulatory antibiotic prescription rates for acute respiratory infection rebound two years after the start of the COVID-19 pandemic.急性呼吸道感染在 COVID-19 大流行开始两年后,门诊抗生素处方率出现反弹。
PLoS One. 2024 Jun 25;19(6):e0306195. doi: 10.1371/journal.pone.0306195. eCollection 2024.
10
How has the emergence of the Omicron SARS-CoV-2 variant of concern influenced worry, perceived risk and behaviour in the UK? A series of cross-sectional surveys.奥密克戎(Omicron)关切变异株的出现如何影响了英国民众的担忧、感知风险和行为?一系列横断面调查。
BMJ Open. 2022 Aug 29;12(8):e061203. doi: 10.1136/bmjopen-2022-061203.

引用本文的文献

1
The role of innate immune system in respiratory viral infection related asthma.固有免疫系统在呼吸道病毒感染相关性哮喘中的作用
Front Cell Infect Microbiol. 2025 Jun 25;15:1604831. doi: 10.3389/fcimb.2025.1604831. eCollection 2025.
2
Population-based study on hospital admissions for pediatric status asthmaticus: from before to after the COVID-19 pandemic.基于人群的儿童重症哮喘住院情况研究:COVID-19大流行之前与之后
Front Pediatr. 2025 May 9;13:1534770. doi: 10.3389/fped.2025.1534770. eCollection 2025.
3
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study.

本文引用的文献

1
Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination.新型冠状病毒2疫苗接种后反应性症状的发病率决定因素及血清学关联
NPJ Vaccines. 2023 Feb 25;8(1):26. doi: 10.1038/s41541-023-00614-0.
2
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).新型冠状病毒2疫苗抗体反应的决定因素:基于人群的纵向研究(英国COVIDENCE)
Vaccines (Basel). 2022 Sep 23;10(10):1601. doi: 10.3390/vaccines10101601.
3
Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK).
自加强疫苗接种以来的时间与新冠病毒相关哮喘加重的新冠病毒疾病严重程度及风险:来自英国COVIDENCE研究数据的纵向分析
BMJ Open Respir Res. 2025 May 15;12(1):e003158. doi: 10.1136/bmjresp-2025-003158.
4
Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian Asthma population.哮喘处方趋势、吸入器依从性和结果:多民族亚洲哮喘人群的真实世界数据分析。
NPJ Prim Care Respir Med. 2024 Nov 3;34(1):35. doi: 10.1038/s41533-024-00391-w.
5
Analysis of Patients Admitted for Asthma Exacerbation in a Tertiary Hospital in Spain.西班牙一家三级医院收治的哮喘急性加重患者分析。
Cureus. 2024 Jun 24;16(6):e63042. doi: 10.7759/cureus.63042. eCollection 2024 Jun.
6
Fleeting victories: COVID-19 and the temporary improvements in asthma care behaviours.短暂的胜利:新冠疫情与哮喘护理行为的临时改善
Lancet Reg Health Eur. 2024 Jun 11;42:100957. doi: 10.1016/j.lanepe.2024.100957. eCollection 2024 Jul.
7
Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care database.2019冠状病毒病大流行期间哮喘急性加重的可改变风险因素:一项基于人群的重复横断面研究,使用研究与监测中心初级保健数据库
Lancet Reg Health Eur. 2024 May 24;42:100938. doi: 10.1016/j.lanepe.2024.100938. eCollection 2024 Jul.
8
Use of infection control measures in people with chronic lung disease: mixed methods study.慢性肺病患者感染控制措施的应用:混合方法研究
ERJ Open Res. 2024 Jan 22;10(1). doi: 10.1183/23120541.00403-2023. eCollection 2024 Jan.
9
Asthma and COVID-19: a controversial relationship.哮喘和 COVID-19:一种有争议的关系。
Virol J. 2023 Sep 7;20(1):207. doi: 10.1186/s12985-023-02174-0.
10
Odds of COVID-19-associated asthma exacerbations in children higher during Omicron wave.奥密克戎变异株流行期间儿童 COVID-19 相关哮喘恶化的几率更高。
Pediatr Pulmonol. 2023 Nov;58(11):3179-3187. doi: 10.1002/ppul.26642. Epub 2023 Aug 18.
队列简介:英国成年人中基于人群的新冠肺炎纵向研究(英国COVIDENCE研究)。
Int J Epidemiol. 2023 Feb 8;52(1):e46-e56. doi: 10.1093/ije/dyac189.
4
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK).接种ChAdOx1 nCoV-19或BNT162b2进行初次疫苗接种后以及接种BNT162b2或mRNA-1273进行加强疫苗接种后感染SARS-CoV-2的风险因素:一项基于人群的队列研究(英国COVIDENCE)
Lancet Reg Health Eur. 2022 Sep 23;22:100501. doi: 10.1016/j.lanepe.2022.100501. eCollection 2022 Nov.
5
Short-term and long-term impacts of COVID-19 on economic vulnerability: a population-based longitudinal study (COVIDENCE UK).COVID-19 对经济脆弱性的短期和长期影响:基于人群的纵向研究(COVIDENCE UK)。
BMJ Open. 2022 Aug 23;12(8):e065083. doi: 10.1136/bmjopen-2022-065083.
6
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.疫苗接种后抗刺突抗体滴度与预防突破性严重急性呼吸综合征冠状病毒 2 感染的相关性:一项基于人群的纵向研究。
J Infect Dis. 2022 Nov 28;226(11):1903-1908. doi: 10.1093/infdis/jiac321.
7
Impact of COVID-19 pandemic on asthma exacerbations: Retrospective cohort study of over 500,000 patients in a national English primary care database.新冠疫情对哮喘急性加重的影响:基于英国一个全国性基层医疗数据库中50多万患者的回顾性队列研究
Lancet Reg Health Eur. 2022 Aug;19:100428. doi: 10.1016/j.lanepe.2022.100428. Epub 2022 Jun 15.
8
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England.在英国,SARS-CoV-2 的 Delta 变异株迅速被奥密克戎(B.1.1.529)取代。
Sci Transl Med. 2022 Jul 6;14(652):eabo5395. doi: 10.1126/scitranslmed.abo5395.
9
Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2-A Report From the US National COVID Cohort Collaborative.美国国家新冠队列协作组关于感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎(B.1.1.529)变异株儿童急性上呼吸道疾病的报告
JAMA Pediatr. 2022 Aug 1;176(8):819-821. doi: 10.1001/jamapediatrics.2022.1110.
10
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK).SARS-CoV-2 疫苗接种前抗体反应的决定因素:一项基于人群的纵向研究(COVIDENCE UK)。
BMC Med. 2022 Feb 22;20(1):87. doi: 10.1186/s12916-022-02286-4.